Vivos Therapeutics, Inc. Retained Earnings
Vivos Therapeutics, Inc. (VVOS) had Retained Earnings of -$138.52 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$138.52M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$133.04M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$125.36M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$118.46M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$138.52M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$133.04M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | -$125.36M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$118.46M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | -$113.06M 10-Q · filed 2025-08-19 | |
| 2025-03-31 | -$108.05M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$104.19M 10-K · filed 2026-04-15 | |
| 2024-09-30 | -$101.36M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$98.74M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$96.81M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | -$93.05M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$88.79M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$86.70M 10-Q · filed 2023-08-16 | |
| 2023-03-31 | -$81.17M 10-Q · filed 2023-06-08 | |
| 2022-12-31 | -$79.47M 10-K/A · filed 2024-07-30 | |
| 2022-09-30 | -$73.38M 10-Q · filed 2022-12-20 | |
| 2022-06-30 | -$67.95M 10-Q · filed 2022-12-20 | |
| 2022-03-31 | -$60.95M 10-Q/A · filed 2022-11-25 | -$61.14M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$55.62M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$48.23M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$42.78M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$38.73M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$35.34M 10-K · filed 2022-03-31 | -$35.33M 10-K · filed 2021-03-25 |
| 2019-12-31 | -$23.28M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |